U.S. researchers working on mice identified monoclonal antibodies that can neutralize the H5N1 avian influenza virus, regular seasonal flu and other strains of influenza A viruses. They hope to use the findings to engineer or discover other monoclonal antibodies that can disable six additional flu strains, including the H3N2 strain of seasonal flu in circulation.

Full Story:

Related Summaries